======= NKX3-2 ======= == Gene Information == * **Official Symbol**: NKX3-2 * **Official Name**: NK3 homeobox 2 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=579|579]] * **UniProt**: [[https://www.uniprot.org/uniprot/P78367|P78367]] * **Interactions**: [[https://thebiogrid.org/search.php?search=NKX3-2&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20NKX3-2|Open PubMed]] * **OMIM**: [[https://omim.org/entry/602183|Open OMIM]] == Function Summary == * **Entrez Summary**: This gene encodes a member of the NK family of homeobox-containing proteins. The encoded protein may play a role in skeletal development. [provided by RefSeq, Jul 2008]. * **UniProt Summary**: Transcriptional repressor that acts as a negative regulator of chondrocyte maturation. PLays a role in distal stomach development; required for proper antral-pyloric morphogenesis and development of antral-type epithelium. In concert with GSC, defines the structural components of the middle ear; required for tympanic ring and gonium development and in the regulation of the width of the malleus (By similarity). {ECO:0000250}. |Homeobox| |intestinal epithelial cell development| |intestinal epithelial cell differentiation| |middle ear morphogenesis| |negative regulation of chondrocyte differentiation| |negative regulation of cartilage development| |spleen development| |animal organ formation| |columnar/cuboidal epithelial cell development| |regulation of chondrocyte differentiation| |regulation of cartilage development| |pancreas development| |columnar/cuboidal epithelial cell differentiation| |ear morphogenesis| |determination of left/right symmetry| |determination of bilateral symmetry| |specification of symmetry| |embryonic skeletal system development| |digestive tract development| |digestive system development| |epithelial cell development| |ear development| |skeletal system morphogenesis| |DNA-binding transcription repressor activity, RNA polymerase II-specific| |sensory organ morphogenesis| |embryonic organ morphogenesis| |sequence-specific DNA binding| |embryonic organ development| |pattern specification process| |transcription by RNA polymerase II| |skeletal system development| |RNA polymerase II proximal promoter sequence-specific DNA binding| |sensory organ development| |embryonic morphogenesis| |hematopoietic or lymphoid organ development| |chordate embryonic development| |transcription, DNA-templated| |nucleic acid-templated transcription| |immune system development| |embryo development ending in birth or egg hatching| |RNA biosynthetic process| |DNA-binding transcription factor activity| |epithelial cell differentiation| |negative regulation of cell differentiation| |tube development| |negative regulation of transcription by RNA polymerase II| |negative regulation of apoptotic process| |anatomical structure formation involved in morphogenesis| |negative regulation of programmed cell death| |negative regulation of developmental process| |animal organ morphogenesis| |embryo development| |negative regulation of cell death| |nucleobase-containing compound biosynthetic process| |epithelium development| |heterocycle biosynthetic process| |aromatic compound biosynthetic process| |negative regulation of transcription, DNA-templated| |negative regulation of multicellular organismal process| |positive regulation of transcription by RNA polymerase II| |negative regulation of nucleic acid-templated transcription| |negative regulation of RNA biosynthetic process| |organic cyclic compound biosynthetic process| |negative regulation of RNA metabolic process| |negative regulation of cellular macromolecule biosynthetic process| |negative regulation of nucleobase-containing compound metabolic process| |negative regulation of macromolecule biosynthetic process| |negative regulation of cellular biosynthetic process| |regulation of apoptotic process| |positive regulation of transcription, DNA-templated| |negative regulation of biosynthetic process| |DNA-binding transcription factor activity, RNA polymerase II-specific| |regulation of programmed cell death| |cellular nitrogen compound biosynthetic process| |positive regulation of nucleic acid-templated transcription| |positive regulation of RNA biosynthetic process| |cell development| |RNA metabolic process| |regulation of cell death| |cellular macromolecule biosynthetic process| |negative regulation of gene expression| |positive regulation of RNA metabolic process| |tissue development| |macromolecule biosynthetic process| |regulation of cell differentiation| |positive regulation of nucleobase-containing compound metabolic process| |positive regulation of macromolecule biosynthetic process| |positive regulation of cellular biosynthetic process| |positive regulation of gene expression| |gene expression| |positive regulation of biosynthetic process| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp17|DABN 20μM R00 exp17]]|-1.87| |[[:results:exp317|Geldanamycin 0.015 to 0.05μM on day4 R07 exp317]]|-1.77| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 15546 * **Expression level (log2 read counts)**: -6.6 {{:chemogenomics:nalm6 dist.png?nolink |}}